Inhibitors of cyclin dependent kinase 7 (cdk7)
US-2024360165-A1 · Oct 31, 2024 · US
This page is not indexed by search engines while we improve data quality.
Schmidt Darby patents
Schmidt Darby is listed as an inventor on 28 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Schmidt Darby |
| Total patents | 28 |
| First publication | Mar 15, 2016 |
| Latest publication | Oct 31, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Use of cell turnover factors for increasing tissue regeneration
US-2024058279-A1 · Feb 22, 2024 · US
Inhibitors of cyclin dependent kinase 7 (cdk7)
US-2023062491-A1 · Mar 2, 2023 · US
Heteroaromatic compounds useful for the treatment of proliferative diseases
US-11040957-B2 · Jun 22, 2021 · US
Inhibitors of cyclin-dependent kinase 7 (cdk7)
US-2021107912-A1 · Apr 15, 2021 · US
Inhibitors of cyclin-dependent kinase 7 (cdk7)
US-2021061803-A1 · Mar 4, 2021 · US
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
US-10906889-B2 · Feb 2, 2021 · US
Inhibitors of cyclin-dependent kinase 7 (CDK7)
US-10865206-B2 · Dec 15, 2020 · US
Inhibitors of cyclin-dependent kinase 7 (cdk7)
US-2020010473-A1 · Jan 9, 2020 · US
Inhibitors of cyclin-dependent kinase 7 (CDK7)
US-10519135-B2 · Dec 31, 2019 · US
Recent patents
Latest publications not already listed above.
Inhibitors of cyclin-dependent kinase 7 (cdk7)
US-2019337940-A1 · Nov 7, 2019 · US
Inhibitors of cyclin-dependent kinase 7 (cdk7)
US-2019330218-A1 · Oct 31, 2019 · US
Heteroaromatic compounds useful for the treatment of proliferative diseases
US-2019292167-A1 · Sep 26, 2019 · US
Heteroaromatic compounds useful for the treatment of proliferative diseases
US-2019241541-A1 · Aug 8, 2019 · US
Inhibitors of cyclin-dependent kinase 7 (CDK7)
US-10336760-B2 · Jul 2, 2019 · US
Inhibitors of cyclin-dependent kinase 7 (CDK7)
US-10308648-B2 · Jun 4, 2019 · US
Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7)
US-2019031642-A1 · Jan 31, 2019 · US
Inhibitors of cyclin-dependent kinase 7 (cdk7)
US-2018319772-A1 · Nov 8, 2018 · US
Inhibitors of cyclin-dependent kinase 7 (CDK7)
US-10106526-B2 · Oct 23, 2018 · US
Inhibitors of cyclin-dependent kinase 7 (CDK7)
US-10059690-B2 · Aug 28, 2018 · US
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
US-10047070-B2 · Aug 14, 2018 · US
Inhibitors of cyclin-dependent kinase 7 (cdk7)
US-2018208578-A1 · Jul 26, 2018 · US
Inhibitors of cyclin-dependent kinase 7 (cdk7)
US-2017183355-A1 · Jun 29, 2017 · US
Inhibitors of cyclin-dependent kinase 7 (cdk7)
US-2017174692-A1 · Jun 22, 2017 · US
Heteromaromatic compounds useful for the treatment of prolferative diseases
US-2016264552-A1 · Sep 15, 2016 · US
Heteroaromatic compounds useful for the treatment of prolferative diseases
US-2016264551-A1 · Sep 15, 2016 · US
Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7)
US-2016264554-A1 · Sep 15, 2016 · US
Soluble guanylate cyclase activators
US-9284301-B2 · Mar 15, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Syros Pharmaceuticals Inc | 22 |
| Dana Farber Cancer Inst Inc | 7 |
| Flagship Pioneering Innovations V Inc | 1 |
| Schmidt Darby | 1 |
| Raghavan Subharekha | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 21 |
| C07D401/14 | 18 |
| C07D471/04 | 17 |
| C07D403/04 | 17 |
| C07D417/14 | 16 |